论文信息 - Development of PEGylated doxorubicin-E-[c(RGDfK)2] conjugate for integrin-targeted cancer therapy - 字舞流文

Development of PEGylated doxorubicin-E-[c(RGDfK)2] conjugate for integrin-targeted cancer therapy

P. Ofek | A. Eldar-Boock | R. Satchi‐Fainaro | Dina Polyak | F. Kratz | K. Licha | A. Many | Claudia Ryppa